Current Cancer Drug Targets
Title:Meet Our Editorial Board Member
Volume: 16 Issue: 5
Author(s): Rodney J.Y. Ho
Affiliation:
Export Options
About this article
Cite this article as:
J.Y. Ho Rodney, Meet Our Editorial Board Member, Current Cancer Drug Targets 2016; 16 (5) . https://dx.doi.org/10.2174/156800961605160523210455
DOI https://dx.doi.org/10.2174/156800961605160523210455 |
Print ISSN 1568-0096 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5576 |
17
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Abnormal Choline Phospholipid Metabolism in Breast and Ovary Cancer:Molecular Bases for Noninvasive Imaging Approaches
Current Medical Imaging Nanoparticle Therapy for Prostate Cancer: Overview and Perspectives
Current Topics in Medicinal Chemistry Conditionally Replicating Adenoviruses for Cancer Treatment
Current Cancer Drug Targets Proline Oxidase (POX) as A Target for Cancer Therapy
Current Drug Targets Listeria monocytogenes as a Vector for Anti-Cancer Therapies
Current Gene Therapy A Guide to Treatment of Sarcoidosis
Current Drug Therapy Recent Patents in Oncolytic Virotherapy
Recent Patents on Biotechnology Effects of Motivational Interview on Awareness, Attitude, and Practice of Breast Self-examination in High-risk Women: A Clinical Trial Study
Current Women`s Health Reviews Synthesis and Evaluation of 4-arylmethyl Curcumin Analgues as Potent Hsp90 Inhibitors
Letters in Drug Design & Discovery 3D-QSAR and Docking Studies on Pyrimidine Derivatives as CSF-1R Inhibitors
Letters in Drug Design & Discovery Proteomics and Epigenetic Mechanisms in Stem Cells
Current Proteomics Copper Transport Systems are Involved in Multidrug Resistance and Drug Transport
Current Medicinal Chemistry Cisplatin Is a DNA-Damaging Antitumour Compound Triggering Multifactorial Biochemical Responses in Cancer Cells: Importance of Apoptotic Pathways
Current Medicinal Chemistry - Anti-Cancer Agents Synthetic Lethality-Based Therapeutics: Perspectives for Applications in Colorectal Cancer
Current Cancer Drug Targets Inhibition of NF-κB and Proteasome Activity in Tumors: Can We Improve the Therapeutic Potential of Topoisomerase I and Topoisomerase II Poisons
Current Pharmaceutical Design Heterocycle-thioacetic Acid Motif: A Privileged Molecular Scaffold with Potent, Broad-Ranging Pharmacological Activities
Current Pharmaceutical Design A Systematic Approach to Vulvodynia
Current Women`s Health Reviews Editorial (Thematic Issue: Combinatorial Fluorophores for Live Cell Imaging)
Combinatorial Chemistry & High Throughput Screening TRP Channels as A Newly Emerging Non-Voltage-Gated Ca2+ Entry Channel Superfamily
Current Pharmaceutical Design Nanotechnology in the Management of Bone Diseases and as Regenerative Medicine
Current Nanoscience